Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on January 8, 2013, reporting events occurring on January 3, 2013. The filing details the entry into a material definitive agreement with Federal Express Corporation (FedEx) to provide frozen shipping logistics services.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on the terms of a new commercial agreement.
Material Changes and Agreement Details
- Agreement Date: Effective January 1, 2013, with a term expiring December 31, 2015.
- Parties: Cryoport, Inc. and Federal Express Corporation.
- Scope: Cryoport will provide frozen shipping logistics using proprietary technologies, including Cryoport Express liquid nitrogen dry vapor shippers (maintaining -150°C for 10+ days) and the Cryoportal Logistics Management Platform.
- Commercial Terms: FedEx will pay a fixed transaction fee based on the region of service and additional fees for related goods or services. There is no minimum volume requirement for FedEx.
- Marketing: FedEx has the non-exclusive right to promote and sell Cryoport's services at its sole expense.
- Technology License: Includes a non-exclusive license for FedEx to use a customized version of the Cryoportal platform, with Cryoport providing maintenance and technical support.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management outlook, or specific risk factors beyond customary representations, warranties, and indemnification obligations included in the agreement. Portions of the agreement were omitted pursuant to a request for confidential treatment.
Investor Verification Checklist
- Verify the specific fee structure and pricing tiers for the fixed transaction fees, as these were redacted for confidential treatment.
- Assess the potential revenue impact of the agreement given the absence of a minimum volume requirement for FedEx.
- Review the attached Exhibit 10.1 for the full text of the agreement and the specific terms of the confidential treatment request.
- Monitor future filings for any financial results or updates related to the performance of this partnership.